Curing Death
  Recent News |  Archives |  Tags |  About |  Newsletter |  Submit News |  Advertise With Us |  Subscribe to CuringDeath.com RSS Fee Subscribe
New Articles
Selenium may slow march of AIDS 12/3/2008

Where does the gene activity of youth go? New findings may hold the key 12/3/2008

Researchers identify genomic causes of a certain type of leukemia relapse 12/2/2008

Master gene plays key role in blood sugar levels 12/2/2008

Researchers recreate SARS virus, open door for potential defenses against future strains 12/2/2008

Scientists discover 21st century plague 12/2/2008

Researchers identify potential new drug target for chronic leukemia 12/1/2008

Radiation before surgery improves pancreatic cancer outcomes 12/1/2008

Scientists show how a protein that determines cell polarity prevents breast cancer 11/30/2008

Researchers identify novel approach for suppressing prostate cancer development 11/30/2008

Genomic signature of colon cancer may individualize treatment 11/29/2008

Cancer cell 'bodyguard' turned into killer 11/29/2008

Vitamin K linked to insulin resistance in older men 11/29/2008

Old flies can become young moms 11/28/2008

Ants may help researchers unlock mysteries of human aging process 11/28/2008

Sugar Helping Profs Map New Ground Against Deadly Bug (9/18/2007)

Tags:
food poisoning, bacteria, cancer

Sugar may help the medicine go down, but what about a medicine that targets sugar to "take down" disease-causing bacteria?

Two University of Guelph researchers are taking this novel route to tackling Clostridium difficile in hopes of eventually developing a safe, effective vaccine against a bug that has sickened and killed people in hospitals and nursing homes across Canada and has threatened various animal species.

Professors Mario Monteiro of Guelph's Department of Chemistry and Scott Weese of the Department of Pathogiology hope their collaborative studies will ultimately lead to a carbohydrate-based vaccine for both people and animals.

No vaccine currently exists for C. difficile, a major cause of diarrhea, particularly among older people in hospitals and nursing homes. Most people are infected in institutions where commonly used antibiotics kill "good" bacteria in the gut, allowing the problem bug to thrive.

There is also evidence that the bacteria also pose a general community health risk and a risk of food-borne disease, Weese said. Last year, he found evidence of C. difficile in ground and processed meats sold in Canada.

Meanwhile, Monteiro has mapped out the chemical structure of polysaccharides, or complex chains of sugars, on the surface of the bacteria.

Learning more about the polysaccharides may ultimately help in developing vaccines based on carbohydrates or carbohydrate-protein complexes, he said.

"They seem to express similar sugar structures, which will make it easier to develop a vaccine that would target different strains of the bacteria," Monteiro said.

While it would take years to develop and test a vaccine for human use, it is possible, he said. New commercially available vaccines for pneumococcal and meningococcal diseases are also based on bacterial surface sugars.

Monteiro's also developing sugar-based vaccines against Campylobacter, which causes food poisoning when improperly cooked chicken is eaten, and Helicobacter pylori, a common gut microbe that can cause gastritis, ulcers and stomach cancer.

Note: This story has been adapted from a news release issued by the University of Guelph

Renegade Motorhomes - Loans - Loan - Credit Counseling

Post Comments:

Search

  Archives |  Submit News |  Advertise With Us |  Contact Us |  Links
All contents © 2000 - 2009 Web Doodle, LLC. All rights reserved.
Web Doodle, LLC does not provide medical advice, diagnosis or treatment. Please read our disclaimer